The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The North America vascular stents market size reached US$ 3.3 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 4.7 Billion by 2027, exhibiting a growth rate (CAGR) of 5.6% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Vascular stents are rigid devices used for providing support to hollow, usually tubular, structures held at a position to prevent arterial blockages. They are usually made up of non-absorbable materials, such as stainless steel or cobalt–chromium alloys, polyethylene and polypropylene. The stents help patients to restore blood flow through arteries during angioplasty. They also help in maintaining the patency of stenotic vessels and avoid re-blockage caused by blood accumulation or excessive tissue growth.
The North America vascular stents market is currently being driven by several factors. The increasing obesity levels, rising smoking and alcohol consumption, and hypertension often lead to various cardiovascular diseases, such as coronary heart and peripheral vascular disorders which require vascular stenting as a treatment. Moreover, there is an escalating demand for advanced devices to cater to the healthcare needs of the increasing geriatric population in the region, thereby driving the vascular stents market. Apart from this, various types of vascular stents, including coronary stents, peripheral vascular stents and EVAR stent grafts, are currently available in the healthcare sector to serve the rising demand. Additionally, rapid technological advancements coupled with the increasing healthcare expenditures in the region have spurred the demand for vascular stents. Furthermore, other benefits, such as short recovery time, low risk of infection, minimized bleeding and lower cost of vascular stents as compared to conventional surgical methods, are expected to fuel the market growth in the region.
IMARC Group provides an analysis of the key trends in each sub-segment of the North America vascular stents market report, along with forecasts at the regional and country level from 2022-2027. Our report has categorized the market based on product type, material, mode of delivery and end-user.
|Base Year of the Analysis||2021|
|Segment Coverage||Product Type, Material, Mode of Delivery, End-User, Country|
|Countries Covered||United States, Canada, Mexico|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2699
Five User License: US$ 3699
Corporate License: US$ 4699
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
Infantile Spasms Therapeutics Market by Therapeutic Class (Anticonvulsants, Corticosteroids, and Others), Drug Type (Vigabatrin, Adrenocorticotropic Hormone, and Others (Phase III)), Dosage (Solid, Liquid), Route of Administration (Oral, Parenteral, and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), End User (Hospitals, Clinics, and Others), and Region 2023-2028
Hyperphosphatemia Drugs Market by Product (Sevelamer, Calcium Based Phosphate Binders, Iron Based Phosphate Binders, Lanthanum Carbonate, and Others), Dosage Form (Tablets, Syrups, Capsules), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region 2023-2028
Urology Robotic Surgery Market by Component (Robotic Surgery Systems, Instruments and Accessories, Services), Application (Robotic Prostatectomy, Robotic Cystectomy, Robotic Pyeloplasty, Robotic Nephrectomy, and Others), and Region 2023-2028
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at